Skip to content

Evaluation of Ayurvedic Management Through Erandmuladi Basti and Shwet Aparajita Churna in Hypothyroidism.

Evaluation Of The Effect Of Erandamuladi Vasti And Shweta Aparajita Churna in Comparision to Thyroxine Sodium In the Management of Hypothyroidism.

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2023/04/051564
Enrollment
30
Registered
2023-04-12
Start date
Unknown
Completion date
Unknown
Last updated
2023-05-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: E02- Subclinical iodine-deficiency hypothyroidism Health Condition 2: E02- Subclinical iodine-deficiency hypothyroidism

Interventions

None listed

Sponsors

Pt Khushilal Sharma Government(Autonomous) College and Institute, Bhopal
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patients those fit for Basti karma 1.Based on thyroid profile elevated level of serum TSH level or low level of serum T3 &T4. However, the cases of which T3 and T4 levels are within normal range and TSH level is high will also included. (TSH value >5.0mIU/ml) 2. Patients those sign the written consent to participate in the study.

Exclusion criteria

Exclusion criteria: All complicated cases of Hypothyroidism, myxedema, severe mental illness, thyroid cancer etc. and other disease associated with endocrine imbalance. 1.Patients having chronic systemic illness. 2.Congenital hypothyroidism 3.Pregnant women and Lactating Mother. 4.Patients having undergone thyroid surgery

Design outcomes

Primary

MeasureTime frame
It is expected that at the end of the study we would be able to demonstrate the effects of Erandmuladi Basti and Shwet Aparajita Churna in the management of hypothyroidism.Timepoint: 45 days

Secondary

MeasureTime frame
It is expected that at the end of the study we would be able to demonstrate the effects of Erandmuladi Basti and Shwet Aparajita Churna in the management of hypothyroidism. It is further expected that this study would be able to provide comparative efficacy between the trialed treatment to that of standard controle ie. Thyroxine sodium. Timepoint: 45 days

Countries

India

Contacts

Public ContactDr Sapna

Pt Khushilal Sharma Government (Autonomous) Ayurveda College and Institute, science Hill

umeshayurvedabhopal@gmail.com9425373046

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026